Skip to main content
HuBei NengTer Technology CO.,Ltd logo

HuBei NengTer Technology CO.,Ltd — Investor Relations & Filings

Ticker · 002102 ISIN · CNE000001Q28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 3,004 across all filing types
Latest filing 2022-11-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002102

About HuBei NengTer Technology CO.,Ltd

https://www.guanfu.com

HuBei NengTer Technology CO.,Ltd specializes in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates. The company is a prominent global supplier of key intermediates for Vitamin E, including trimethylhydroquinone and isophytol, utilizing proprietary catalytic technologies. Its product portfolio also encompasses high-end chiral chemicals and intermediates for cardiovascular medications, such as statins. HuBei NengTer focuses on technological innovation in chemical synthesis, aiming for high-efficiency and environmentally sustainable manufacturing processes. The company serves international markets, providing essential raw materials for the pharmaceutical, nutraceutical, and animal nutrition sectors.

Recent filings

Filing Released Lang Actions
独立董事关于公司向控股股东借款暨关联交易的事前同意函
Regulatory Filings Classification · 95% confidence The document is a formal letter from independent directors providing prior consent for a related-party transaction involving a loan from the controlling shareholder to the company. It references compliance with Chinese securities regulations and company rules. The document is short (767 characters) and is a specific approval letter rather than a full report or announcement of voting results. It is not an annual report, audit report, earnings release, or any other financial report type. It is also not a regulatory filing or announcement of a report publication. The content fits best with a Regulatory Filings (RNS) category as it is a compliance-related document concerning a related-party transaction and independent director opinion, which does not fit other more specific categories.
2022-11-09 Chinese
关于与同孚实业私募债项目相关债权人签署和解协议书的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding the signing of settlement agreements related to disputes and lawsuits arising from overdue private bonds guaranteed by the company. It details the background of the dispute, the terms of the settlement, the parties involved, and the potential impact on the company's profits. There is no presentation of financial statements or detailed financial performance data, but rather a disclosure of legal and financial risk resolution and its accounting impact. The document is a formal public announcement of a legal settlement and related financial impact, not a full audit report, annual report, or earnings release. It fits best under Legal Proceedings Report (LTR) as it updates on significant lawsuits and regulatory actions involving the company. The document length is 3856 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is LTR with high confidence.
2022-11-09 Chinese
第七届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 冠福控股股份有限公司. It details the convening of the seventh board's sixth meeting, the voting results on a related-party transaction (loan from controlling shareholder), and mentions independent directors' opinions. There is no financial data, no report attached or referenced as being published, and no mention of regulatory certifications or filings. The content focuses on board decisions and management actions, specifically about a related-party transaction. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2022-11-09 Chinese
第七届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board of a company regarding a related party transaction (loan from controlling shareholder). It includes voting results and references a detailed announcement published elsewhere. The document is short (643 characters) and primarily serves as a formal announcement of a board decision rather than a full report or financial statement. It does not contain financial data or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-09 Chinese
独立董事关于关于公司向控股股东借款暨关联交易的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from the independent directors regarding a related-party transaction involving a loan from the controlling shareholder to the company. It references compliance with securities regulations and company rules, and it provides an independent directors' approval statement on the transaction. The document is short (863 characters) and does not contain financial statements or detailed financial data. It is a formal opinion related to governance and compliance on a specific transaction, not a full audit report or annual report. This fits best under the category of Regulatory Filings (RNS), as it is a regulatory disclosure related to a corporate governance matter and related-party transaction, but not a full audit or financial report.
2022-11-09 Chinese
关于与债权人中信商业保理有限公司深圳分公司签署《执行和解协议》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding the signing of a settlement agreement with a creditor related to litigation and debt disputes. It details the background of the disputes, the terms of the settlement, potential impacts on profits, and risk warnings. The document does not contain financial statements or detailed financial data but rather provides information about legal and financial dispute resolution and related company disclosures. It is not an annual report, audit report, earnings release, or any form of financial statement. It is also not a regulatory certification or a report publication announcement. The content fits best under a Regulatory Filings (RNS) category as it is a general regulatory announcement about a legal and financial matter involving the company, without fitting into more specific categories like Legal Proceedings Report (LTR) because it is primarily about the settlement announcement rather than ongoing litigation details or updates.
2022-10-31 Chinese

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.